Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 369

1.

Uncertainties for endocrine disrupters: our view on progress.

Daston GP, Cook JC, Kavlock RJ.

Toxicol Sci. 2003 Aug;74(2):245-52. Epub 2003 May 2. Review.

2.

In vitro models in endocrine disruptor screening.

Charles GD.

ILAR J. 2004;45(4):494-501. Review.

4.

Use of the laboratory rat as a model in endocrine disruptor screening and testing.

Gray LE Jr, Wilson V, Noriega N, Lambright C, Furr J, Stoker TE, Laws SC, Goldman J, Cooper RL, Foster PM.

ILAR J. 2004;45(4):425-37. Review.

5.

Evaluation of Tier I screening approaches for detecting endocrine-active compounds (EACs).

O'Connor JC, Cook JC, Marty MS, Davis LG, Kaplan AM, Carney EW.

Crit Rev Toxicol. 2002;32(6):521-49. Review.

PMID:
12487364
6.

Endocrine disruptors and reproductive development: a weight-of-evidence overview.

Cooper RL, Kavlock RJ.

J Endocrinol. 1997 Feb;152(2):159-66. Review.

PMID:
9071972
7.

The U.S. federal framework for research on endocrine disruptors and an analysis of research programs supported during fiscal year 1996.

Reiter LW, DeRosa C, Kavlock RJ, Lucier G, Mac MJ, Melillo J, Melnick RL, Sinks T, Walton BT.

Environ Health Perspect. 1998 Mar;106(3):105-13.

8.

Answering the endocrine test questions.

Schmidt CW.

Environ Health Perspect. 1999 Sep;107(9):A458-60.

9.
10.

Endocrine disrupting chemicals research program of the U.S. Environmental Protection Agency: summary of a peer-review report.

Harding AK, Daston GP, Boyd GR, Lucier GW, Safe SH, Stewart J, Tillitt DE, Van Der Kraak G.

Environ Health Perspect. 2006 Aug;114(8):1276-82.

11.

Overview of endocrine disruptor research activity in the United States.

Kavlock RJ.

Chemosphere. 1999 Oct;39(8):1227-36. Review.

PMID:
10467717
12.

Xenoendocrine disrupters-tiered screening and testing: filling key data gaps.

Gray LE Jr, Ostby J, Wilson V, Lambright C, Bobseine K, Hartig P, Hotchkiss A, Wolf C, Furr J, Price M, Parks L, Cooper RL, Stoker TE, Laws SC, Degitz SJ, Jensen KM, Kahl MD, Korte JJ, Makynen EA, Tietge JE, Ankley GT.

Toxicology. 2002 Dec 27;181-182:371-82. Review.

PMID:
12505339
14.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
15.

Endocrine disrupters--testing strategies to assess human hazard.

Baker VA.

Toxicol In Vitro. 2001 Aug-Oct;15(4-5):413-9. Review.

PMID:
11566572
16.
18.

Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.

Pickford DB.

Crit Rev Toxicol. 2010 Nov;40(10):845-92. doi: 10.3109/10408444.2010.494250. Review.

PMID:
20684730
19.

Endocrine disruption comes into regulatory focus.

Baltz D.

New Solut. 1999;9(1):29-35.

PMID:
17208914
20.

Approaches to the assessment of toxicity data with endpoints related to endocrine disruption.

Harvey PW, Johnson I.

J Appl Toxicol. 2002 Jul-Aug;22(4):241-7. Review.

PMID:
12210541
Items per page

Supplemental Content

Write to the Help Desk